Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/9/2025

Metastatic Prostate Cancer Diagnosis and Management

Diagnostic Criteria

  • A PSA level >10 ng/mL carries a >50% probability of prostate cancer, according to the European Association of Urology 1, 2
  • The markedly elevated alkaline phosphatase strongly suggests bone metastases, as recommended by the European Society for Medical Oncology 1, 2
  • Back pain in the context of prostate cancer typically indicates vertebral metastases, as stated by the American Urological Association 1
  • The combination of obstructive urinary symptoms, back pain, and laboratory findings creates a highly specific pattern for metastatic prostate cancer, according to the National Comprehensive Cancer Network 1, 2

Differential Diagnosis

  • Alkaline phosphatase would remain normal in prostatitis, as noted by the American Urological Association 5
  • BPH does not cause elevated alkaline phosphatase, as stated by the European Association of Urology 5
  • BPH does not typically cause back pain, according to the American Urological Association 5

Diagnostic Workup

  • Bone scintigraphy is mandatory given PSA >10 mg/L and clinical suspicion of bone metastases, as recommended by the European Society for Medical Oncology 1, 2, 3, 4
  • Tissue diagnosis via transrectal ultrasound-guided biopsy should be obtained, according to the National Comprehensive Cancer Network 1, 2, 3, 4

Urgent Considerations

  • Do not delay imaging for potential spinal cord compression - back pain with neurologic symptoms requires urgent MRI to exclude epidural metastases requiring emergency intervention, as stated by the American College of Radiology 1